Patents by Inventor Karsten Maeder

Karsten Maeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTABLE AND IMPLANTABLE CARRIER SYSTEMS BASED ON MODIFIED POLY(DICARBOXYLIC ACID MULTI-OIL ESTERS) FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENT
    Publication number: 20170151334
    Abstract: Modified poly(dicarboxylic acid multiol esters) are suitable as carriers for bioactive substances, especially as injectable implants, without further additives. The polymers can be directly injected without using an organic solvent. Furthermore, modified poly(dicarboxylic acid multiol esters) can be mixed with suitable biocompatible organic solvents and injected or realized as implants. The carriers are suitable for controlled active ingredient release in human and veterinary medicine.
    Type: Application
    Filed: April 22, 2015
    Publication date: June 1, 2017
    Inventors: Karsten MAEDER, Verena WEISS, Joerg KRESSLER, Toufik NAOLOU
  • Lipase inhibiting composition
    Patent number: 8343543
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: January 1, 2013
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Karsten Maeder, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Schroeder
  • LIPASE INHIBITING COMPOSITION
    Publication number: 20110301231
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Application
    Filed: August 19, 2011
    Publication date: December 8, 2011
    Inventors: Karsten MAEDER, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Shroeder
  • Lipase inhibiting composition
    Patent number: 8039508
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: October 18, 2011
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Karsten Maeder, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Schroeder
  • Lipase inhibiting composition
    Publication number: 20050101562
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ?37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Application
    Filed: December 23, 2004
    Publication date: May 12, 2005
    Inventors: Karsten Maeder, Rainer Martin, Susanne Raab, Lukas Scheibler, Thomas Schindler, Marco Schroeder
  • Pharmaceutical compositions having depressed melting points
    Patent number: 6730319
    Abstract: The present invention relates to pharmaceutical compositions that contain a solid pharmaceutically active compound having a melting point ≧37° C. and a fatty acid or a fatty acid salt or a mixture of a fatty acid and a fatty acid salt. Such composition results in a depression in melting point to ≦37° C. upon contact with an aqueous solution thereby providing an improved outlook for absorption.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: May 4, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Karsten Maeder, Lukas Christoph Scheibler, Hans Steffen
  • Pharmaceutical compositions having depressed melting points
    Publication number: 20030039686
    Abstract: The present invention relates to pharmaceutical compositions that contain a solid pharmaceutically active compound having a melting point ≧37° C. and a fatty acid or a fatty acid salt or a mixture of a fatty acid and a fatty acid salt. Such composition results in a depression in melting point to ≦37° C. upon contact with an aqueous solution thereby providing an improved outlook for absorption.
    Type: Application
    Filed: May 23, 2002
    Publication date: February 27, 2003
    Inventors: Karsten Maeder, Lukas C. Scheibler, Hans Steffen
  • Lipase inhibiting composition
    Publication number: 20030027786
    Abstract: Pharmaceutical compositions that contain a lipase inhibitor having a melting point ≧37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
    Type: Application
    Filed: May 23, 2002
    Publication date: February 6, 2003
    Inventors: Karsten Maeder, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Schroeder